Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

On Monday, AI powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference by announcing new and expanded ...

The New York-based company, previously known as VantAI and incubated at Roivant before a spinoff, is working in a ...

Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Schrödinger (SDGR) and Revvity (RVTY) on Friday announced collaborations with Eli Lilly (LLY) to integrate their respective ...

Abstract: Structure-based drug design (SBDD) is a critical subtask in the drug discovery process, with deep generative models playing a pivotal role. Inherently, drug design is a multi-objective task ...

This essay is part of a First Opinion series on the future of the National Institutes of Health and American science. Around the world, nations with robust research and development infrastructure race ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to further energize development of its “computer-aided design suite” for new ...

The deal to acquire the Hollywood behemoth’s television and film studios as well as HBO Max will bulk up the world’s biggest paid streaming service. By Brooks Barnes Lauren Hirsch and Nicole Sperling ...

Inside a lab at the Massachusetts Institute of Technology late last year, scientists gave an AI system a new task: designing entirely new molecules for potential antibiotics from scratch. Within a day ...

AlphaFold’s impact on the research world has been astronomical. At ELRIG’s Drug Discovery 2025 (21–22 October; Liverpool, UK), we had the opportunity to speak with Miles Congreve (left), Chief ...